Development and treatment of permeation nodules in cancer of the breast
Petrovanu, C.; Gălesanu, M.R.; Carasevici, E.; Sandica, T.
Revista Medico-Chirurgicala a Societatii de Medici Si Naturalisti Din Iasi 79(2): 267-272
1975
ISSN/ISBN: 0048-7848 PMID: 1166164 Document Number: 90522
Document emailed within 1 workday
Related Documents
Vetshev, P.S.; Kuznetsov, N.S.; Bel'tsevich, D.G.; Ozerov, S.K. 1997: Potentialities of ultrasound examination in differential diagnosis of benign nodules and breast cancer Khirurgiia 6: 15-20Pinedo, H.M. 2000: New development of treatment for locally advanced breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 27(Suppl 2): 272-273
Yamashita, T.; Iwata, K. 2009: New development in the treatment of breast cancer. II. Future anti-HER2 therapy Gan to Kagaku Ryoho. Cancer and ChemoTherapy 36(13): 2551-2554
Toh, U.; Saku, S.; Okabe, M.; Iwakuma, N.; Kimitsuki, Y.; Akashi, M.; Ogo, E.; Yamada, A.; Shichijo, S.; Itoh, K.; Akagi, Y. 2016: Development of Peptide Vaccines for Triple-Negative Breast Cancer Treatment Gan to Kagaku Ryoho. Cancer and ChemoTherapy 43(10): 1249-1251
Planchon, P.; Magnien, V.; Beaupain, R.; Mainguene, C.; Ronco, G.; Villa, P.; Brouty-Boye, D. 1992: Differential effects of butyrate derivatives on human breast cancer cells grown as organotypic nodules in vitro and as xenografts in vivo In Vivo 6(6): 605-610
Fürst, W.; Neubert, R.; Förster, B.; Reppel, L. 1980: Drug permeation through synthetic lipid membranes. Part 13: the effects of tensides on the permeation of ionized drugs Die Pharmazie 34(5-6): 315-316
Bhattacharya, A.; Ghosal, S.K. 2000: Permeation kinetics of ketotifen fumarate alone and in combination with hydrophobic permeation enhancers through human cadaver epidermis Bollettino Chimico Farmaceutico 139(4): 177-181
Andersen, J.; Nielsen, M.; Christensen, L.; Ottesen, G.L.; Blichert-Toft, M. 1987: The significance of the frequency and occurrence of breast cancer for treatment. Essential aspects of new Danish studies of the natural history of breast cancer Acta Chirurgica Belgica 87(2): 103-107
Wahner-Roedler, D.L.; Petersen, I.A. 2004: Risk of breast cancer and breast cancer characteristics in women after treatment for Hodgkin lymphoma Drugs of Today 40(10): 865-879
Thomsen, K. 1987: Changes in the therapy of operable breast cancer. Treatment of small breast cancer and preinvasive stages Fortschritte der Medizin 105(22): 425-428
Rintasyöpäryhmä ry, S. 1997: Recommended treatment guideline for breast cancer. Finnish Breast Cancer Group Duodecim; Laaketieteellinen Aikakauskirja 113(22): 2341-2348
Lipkus, I.M.; Iden, D.; Terrenoire, J.; Feaganes, J.R. 1999: Relationships among breast cancer concern, risk perceptions, and interest in genetic testing for breast cancer susceptibility among African-American women with and without a family history of breast cancer Cancer Epidemiology Biomarkers and Prevention: a Publication of the American Association for Cancer Research Cosponsored by the American Society of Preventive Oncology 8(6): 533-539
Kaufmann, M.; Jonat, W.; Eiermann, W.; Maass, H.; Bastert, G. 1990: Breast saving operation and adjuvant therapy of breast cancer. Report of the National Institute of Health (NIH) consensus development conference, Washington, D.C., USA, 18-21 June 1990 Onkologie 13(5): 394-396
2004: Adjuvant chemotherapy for early breast cancer: protocol and nonprotocol treatment options. Proceedings of a national research leader think tank and 3 regional breast cancer update working group meetings. July-October 2003 Oncology 18(4 Suppl. 1): 5-22
Rosselli Del Turco, M.; Palli, D.; Cariddi, A.; Ciatto, S.; Pacini, P.; Distante, V. 1994: Intensive diagnostic follow-up after treatment of primary breast cancer. A randomized trial. National Research Council Project on Breast Cancer follow-up JAMA 271(20): 1593-1597
Tominaga, T. 1999: Recent development of oral anti-cancer drugs for breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 26(3): 301-307
Axelsson, C.K.; Andersen, J.A.; Andersen, K.W.; Blichert-Toft, M.; Dombernowsky, P.; Hansen, M.; Krag, C.; Mouridsen, H.T.; Overgaard, M.; Rasmussen, B.B. 1991: Prognosis after surgical treatment of breast cancer. 3. The low-risk group of the DBCG (Danish Breast Cancer Cooperative Group) Ugeskrift for Laeger 153(33): 2276-2279
1997: Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Breast Cancer Linkage Consortium Lancet 349(9064): 1505-1510
1974: Assessment of response to treatment in advanced breast cancer. British Breast Group Lancet 2(7871): 38-39
Adami, H.O.; Aspegren, K.; Graffman, S.; Holmberg, L. 1987: Breast-sparing surgery in the treatment of breast cancer--report of the current status Lakartidningen 84(15): 1262-1265